Cargando…

Association Between the TP53 Polymorphisms and Breast Cancer Risk: An Updated Meta-Analysis

Background: The relationship of TP53 codons 72, IVS3 16 bp, and IVS6+62A > G polymorphisms with breast cancer (BC) risk has been analyzed in seventeen published meta-analyses. However, the credibility of statistically significant associations was ignored and many new studies have been reported on...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lin, Yin, Xiang-Xiongyi, Qin, Jun, Wang, Wei, He, Xiao-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091657/
https://www.ncbi.nlm.nih.gov/pubmed/35571038
http://dx.doi.org/10.3389/fgene.2022.807466
_version_ 1784704973809909760
author Zhao, Lin
Yin, Xiang-Xiongyi
Qin, Jun
Wang, Wei
He, Xiao-Feng
author_facet Zhao, Lin
Yin, Xiang-Xiongyi
Qin, Jun
Wang, Wei
He, Xiao-Feng
author_sort Zhao, Lin
collection PubMed
description Background: The relationship of TP53 codons 72, IVS3 16 bp, and IVS6+62A > G polymorphisms with breast cancer (BC) risk has been analyzed in seventeen published meta-analyses. However, the credibility of statistically significant associations was ignored and many new studies have been reported on these themes. Objectives: To explore whether TP53 codons 72, IVS3 16 bp, and IVS6+62A > G polymorphisms are associated with BC risk and the clinical phenomena. Methods: To comprehensively search the data (through October 25, 2021), we provided a clear search strategy and reviewed the references of published meta-analyses. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) were used. Results: The current meta-analysis had a larger sample size than the previous ones: 99 studies with 43,951 BC and 48,479 controls for TP53 codon 72 polymorphism, 35 studies with 8,705 BC and 7,516 controls for IVS3 16 bp polymorphism, and 25 studies with 12,222 BC and 12,895 controls for IVS6+62A > G polymorphism. Five gene models were used to explore the association between the three polymorphisms and BC risk, and partial positive results were similar to published meta-analyses results. However, a large number of significant results were considered to be unreliable after correcting with Bayesian false-discovery probability (BFDP), except for the association between TP53 IVS3 16 bp polymorphism and BC risk in overall analysis (GG vs. CC: BFDP = 0.738), matched studies (GG vs. CC: BFDP = 0.173; GG vs. CC + CG: BFDP = 0.447), and tumor size below 2 cm (GG vs. CC: BFDP = 0.088; GG + CG vs. CC: BFDP = 0.730; GG vs. CC + CG: BFDP = 0.311). These unreliable results were confirmed again without new solid results emerging in further sensitivity analysis (only studies in compliance with the quality assessment standard). Conclusion: After considering the quality of the included studies and the reliability of the results, the present meta-analysis suggested that TP53 codons 72, IVS3 16 bp, and IVS6+62A > G polymorphisms were not significantly associated with the BC risk. Those results which prove that these three polymorphisms increase BC risk are more likely to be false-positive results due to various confounding factors.
format Online
Article
Text
id pubmed-9091657
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90916572022-05-12 Association Between the TP53 Polymorphisms and Breast Cancer Risk: An Updated Meta-Analysis Zhao, Lin Yin, Xiang-Xiongyi Qin, Jun Wang, Wei He, Xiao-Feng Front Genet Genetics Background: The relationship of TP53 codons 72, IVS3 16 bp, and IVS6+62A > G polymorphisms with breast cancer (BC) risk has been analyzed in seventeen published meta-analyses. However, the credibility of statistically significant associations was ignored and many new studies have been reported on these themes. Objectives: To explore whether TP53 codons 72, IVS3 16 bp, and IVS6+62A > G polymorphisms are associated with BC risk and the clinical phenomena. Methods: To comprehensively search the data (through October 25, 2021), we provided a clear search strategy and reviewed the references of published meta-analyses. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) were used. Results: The current meta-analysis had a larger sample size than the previous ones: 99 studies with 43,951 BC and 48,479 controls for TP53 codon 72 polymorphism, 35 studies with 8,705 BC and 7,516 controls for IVS3 16 bp polymorphism, and 25 studies with 12,222 BC and 12,895 controls for IVS6+62A > G polymorphism. Five gene models were used to explore the association between the three polymorphisms and BC risk, and partial positive results were similar to published meta-analyses results. However, a large number of significant results were considered to be unreliable after correcting with Bayesian false-discovery probability (BFDP), except for the association between TP53 IVS3 16 bp polymorphism and BC risk in overall analysis (GG vs. CC: BFDP = 0.738), matched studies (GG vs. CC: BFDP = 0.173; GG vs. CC + CG: BFDP = 0.447), and tumor size below 2 cm (GG vs. CC: BFDP = 0.088; GG + CG vs. CC: BFDP = 0.730; GG vs. CC + CG: BFDP = 0.311). These unreliable results were confirmed again without new solid results emerging in further sensitivity analysis (only studies in compliance with the quality assessment standard). Conclusion: After considering the quality of the included studies and the reliability of the results, the present meta-analysis suggested that TP53 codons 72, IVS3 16 bp, and IVS6+62A > G polymorphisms were not significantly associated with the BC risk. Those results which prove that these three polymorphisms increase BC risk are more likely to be false-positive results due to various confounding factors. Frontiers Media S.A. 2022-04-27 /pmc/articles/PMC9091657/ /pubmed/35571038 http://dx.doi.org/10.3389/fgene.2022.807466 Text en Copyright © 2022 Zhao, Yin, Qin, Wang and He. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Zhao, Lin
Yin, Xiang-Xiongyi
Qin, Jun
Wang, Wei
He, Xiao-Feng
Association Between the TP53 Polymorphisms and Breast Cancer Risk: An Updated Meta-Analysis
title Association Between the TP53 Polymorphisms and Breast Cancer Risk: An Updated Meta-Analysis
title_full Association Between the TP53 Polymorphisms and Breast Cancer Risk: An Updated Meta-Analysis
title_fullStr Association Between the TP53 Polymorphisms and Breast Cancer Risk: An Updated Meta-Analysis
title_full_unstemmed Association Between the TP53 Polymorphisms and Breast Cancer Risk: An Updated Meta-Analysis
title_short Association Between the TP53 Polymorphisms and Breast Cancer Risk: An Updated Meta-Analysis
title_sort association between the tp53 polymorphisms and breast cancer risk: an updated meta-analysis
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091657/
https://www.ncbi.nlm.nih.gov/pubmed/35571038
http://dx.doi.org/10.3389/fgene.2022.807466
work_keys_str_mv AT zhaolin associationbetweenthetp53polymorphismsandbreastcancerriskanupdatedmetaanalysis
AT yinxiangxiongyi associationbetweenthetp53polymorphismsandbreastcancerriskanupdatedmetaanalysis
AT qinjun associationbetweenthetp53polymorphismsandbreastcancerriskanupdatedmetaanalysis
AT wangwei associationbetweenthetp53polymorphismsandbreastcancerriskanupdatedmetaanalysis
AT hexiaofeng associationbetweenthetp53polymorphismsandbreastcancerriskanupdatedmetaanalysis